Drugs / Salmonella typhi polysaccharide vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03968211 | Jul 2019 → Dec 2023 | immunodeficiency disease | University of Virginia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salmonella typhi polysaccharide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03968211 ↗ |
| Modality | Vaccine | “Salmonella typhi polysaccharide vaccine” NCT03968211 ↗ |
| Route | Intramuscular | “administered a single intramuscular dose of the Salmonella typhi polysaccharide vaccine” NCT03968211 ↗ |